Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.

Nu Skin Enterprises to Announce First Quarter 2024 Financial Results

Icahn Enterprises

AT&T

Dividends that provide a passive source of revenue for investors often seem great on the surface. Stocks with high yields can sometimes indicate a company's instability or solely serve the purpose of attracting investors without offering sustainable returns.

High-Yield Dividend Stocks to Avoid: 3 Dangerous Picks

Nu Skin (NUS) is battling macroeconomic challenges, with inflation putting pressure on consumer spending and customer acquisition. Management expects revenues to decline in 2024.

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

The new self-care system uses unique adaptive microcurrent technology to help the body restore, revitalize and refresh through skin stimulation PROVO, Utah , Feb. 27, 2024 /PRNewswire/ -- Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.

Nu Skin Launches RenuSpa iO, a New Personalized Beauty and Wellness Device

Herbalife

Stryve Foods

Universal Corp

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 4 Risk Off Stocks That May Explode In February - Herbalife (NYSE:HLF), Nu Skin Enterprises (NYSE:NUS)

Nu Skin delivered a better-than-feared quarter to end 2023. The personal care products company is grappling with macro headwinds amid an ongoing restructuring plan.

Why Nu Skin Enterprises Stock Plunged Today

Nu Skin's (NUS) fourth-quarter 2023 results reflect the persistence of macroeconomic challenges and hurdles related to business transformation, offset by growth in some regions.

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.89 per share a year ago.

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

Nu Skin Enterprises, Inc. (NUS) Q4 2023 Earnings Call Transcript

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance. Executive Summary Q4 2023 vs. Prior-year Quarter Revenue $488.6 million; (6)% (1)% FX impact or $(7.2) million Rhyz revenue $65.1 million; 101% Earnings Per Share (EPS) $0.15 or $0.37 excluding restructuring and other charges, compared to $1.15 or $0.89 excluding restructuring and impairment charges and a favorable tax rate in Q4 22 Cus.

Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance

Nu Skin's (NUS) fourth-quarter 2023 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations pose concerns.

Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

Frontline

Medifast

Omega Healthcare Investors

PennantPark Floating Rate Capital

We decided to screen our 24/7 Wall St. dividend research database for companies that pay gigantic dividends that investors have likely never heard of.

5 Stocks You Have Never Heard of Pay Massive Dividends

Dominion Energy

Foot Locker

Investing in high-yield dividend stocks is one of the best ways to accumulate wealth to fund your retirement. For the better part of a century, dividend-paying companies have far outperformed non-payers with less risk.

Dividend Danger Zone: 3 High-Yield Stocks That Could Follow in Walgreens' Footsteps

Ares Capital

British American Tobacco

MPLX

OneMain Hld

This company is a high-yielding Business Development Company (BDC) paying a massive 9.41% dividend.

7 ‘Strong Buy' Ultra Dividend Leaders To Grab Before It's Too Late

Devon Energy

Plains All American Pipeline

Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In other words, the actual investment or portfolio return consists of income and stock appreciation.

5 High-Yield Dividend Stocks With Double Digit Upside, According to Wall Street

Nu Skin (NUS) is benefiting from the Nu Vision 2025 strategy driven by a dynamic affiliate opportunity platform. However, escalating macroeconomic pressures are hampering key markets.

Product Launches Aid Nu Skin (NUS), Macroeconomic Hurdles Ail

PROVO, Utah--(BUSINESS WIRE)--Nu Skin execs are scheduled to present at ICR Conference. The company also shared Q4 preliminary revenue with full results to be reported Feb. 14.

Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference

Abercrombie & Fitch

ANSYS

Century Aluminum

Check Point Software Technologies

FTI Consulting

FactSet Research Systems

Guess?

Hub Group

Iron Mountain

Lithia Motors

Pegasystems

Stericycle

Steel Dynamics

TTEC Holdings

ViaSat

The year 1996 was a record one for initial public offerings (IPOs).

16 Companies With IPOs in 1996: Best and Worst Performers

Nu Skin (NUS) is battling escalating macroeconomic pressures, which are hampering key markets of the core business. Unfavorable currency translations remain a major concern.

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?

$55 million investment increases manufacturing capacity and agility for beauty and wellness company's business in Asia PROVO, Utah , Nov. 29, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the opening of its new manufacturing facility in Shanghai, China. Nu Skin has invested approximately $55 million in the new facility over the past few years, which will increase production capacity and supply chain responsiveness for the company in China and its other Asian markets.

Nu Skin Opens New Manufacturing Facility in China

Ardmore Shipping

Bancolombia

DHT Holdings

Energy Transfer LP Unit

Euronav

FS KKR Capital Corp

HSBC Holdings

Dorian LPG

Magic Software Enterprises

Altria

New York Community Bancorp

Blue Owl Capital Corp

Petroleo Brasileiro

Sibanye Stillwater

Sociedad Quimica Y Minera De Chile

TORM

"Value ranking, looks at the price of a stock relative to intrinsic firm value. Graham Value Stocks match the criteria Benjamin Graham followed." - YCharts Value Screener. 70 December Value large caps and Graham formula-derived results reflect established value-stock detection-criteria. Of those, 56 met the dogcatcher-Delirious-ideal of dividends from $1K invested, exceeding their single-share-stock-prices. Representing nine-of-eleven Morningstar Sectors, all 56 ideal value-picks pay regular-dividends. Broker-target-top-ten net-gains ranged 30.91%-70.83%, topped by SBSW & SQM, as-of 11/21/23.

56 Delicious December Value Buys From Ben Graham's Formula

Enphase Energy

Sanmina-SCI

In financial markets, astute investors are always looking for under-the-radar stocks with the potential for explosive growth. In this era of sustainability, technological innovation, and diversified markets, three companies have emerged as compelling investment opportunities.

Billionaire's Blueprint: 3 Under-the-Radar Stocks Ready for Massive Growth

Nu Skin (NUS) faces challenging y/y comparisons and macroeconomic hurdles in Q3, leading to a downward revision in its revenue and EPS projections for 2023.

Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance

News for Nu Skin Enterprises Stock (NUS)